Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-18-003129
Filing Date
2018-02-22
Accepted
2018-02-22 17:30:42
Documents
1
Period of Report
2018-02-20

Document Format Files

Seq Description Document Type Size
1 MATHIESEN FORM 4 2-20-18 rdgdoc.html 4  
1 MATHIESEN FORM 4 2-20-18 rdgdoc.xml 4 4988
  Complete submission text file 0001437749-18-003129.txt   6517
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Issuer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 43334 SEVEN MILE RD. SUITE 1000 NORTHVILLE MI 48167
Business Address
MATHIESEN JEFFREY S (Reporting) CIK: 0001296853 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55242 | Film No.: 18633710